Arginine and asthma

Nestle Nutrition Institute Workshop Series

Volumn 77, Issue , 2013, Pages 1-15

  Morris, Claudia R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AIRWAY REMODELING; ASTHMA; DEFICIENCY; ENZYMOLOGY; HUMAN; INFLAMMATION; METABOLISM;

AIRWAY REMODELING; ARGINASE; ARGININE; ASTHMA; HUMANS; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 84898629204     PISSN: 16642147     EISSN: 16642155     Source Type: Book Series    
DOI: 10.1159/000351365     Document Type: Conference Paper

References (74)

1. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001; 344: 350-362.
2. NHLBI: Expert Panel Report 3: Guidelines for the diagnosis and management of asthma; in National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program, 2007.
3. Gaston B: The biochemistry of asthma. Biochim Biophys Acta 2011; 1810: 1017-1024.
4. Ricciardolo FL, Sterk PJ, Gaston B, et al: Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84: 731-765.
5. Redington AE: Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur J Pharmacol 2006; 533: 263-276.
6. Jatakanon A, Lim S, Kharitonov S, et al: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91-95.
7. de Boer J, Meurs H, Flendrig L, et al: Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol 2001; 133: 1235-1242.
8. Maarsingh H, Bossenga BE, Bos IS, et al: Larginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur Respir J 2009; 34: 191-199.
9. Takemoto K, Ogino K, Shibamori M, et al: Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1419-L1426.
10. Morris SM Jr: Arginine: beyond protein. Am J Clin Nutr 2006; 83: 508S-512S.
11. Morris CR, Poljakovic M, Lavisha L, et al: Decreased arginine bioavailability and increased arginase activity in asthma. Am J Respir Crit Care Med 2004; 170: 148-153.
12. Lara A, Khatri SB, Wang Z, et al: Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008; 178: 673-681.
13. Wu G, Morris SM: Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
14. Morris CR: Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol 2009; 84: 234-241.
15. Morris CR, Kato GJ, Poljakovic M, et al: Dysregulated arginine metabolism, hemolysisassociated pulmonary hypertension and mortality in sickle cell disease. JAMA 2005; 294: 81-90.
16. Morris CR: Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008; 2008: 177-185.
17. Kenyon NJ, Bratt JM, Linderholm AL, et al: Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: source and consequences. Toxicol Appl Pharmacol 2008; 230: 269-275.
18. Maarsingh H, Tio MA, Zaagsma J, et al: Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res 2005; 6: 23.
19. Ogino K, Kubo M, Takahashi H, et al: Antiinflammatory effect of arginase inhibitor and corticosteroid on airway allergic reactions in a Dermatophogoides farinae-induced NC/Nga mouse model. Inflammation 2013; 36: 141-151.
20. Meurs H, McKay S, Maarsingh H, et al: Increased arginase activity underlies allergeninduced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002; 136: 391-398.
21. Maarsingh H, Leusink J, Bos ISS, et al: Arginase strongly impairs neuronal nitric oxidemediated airway smooth muscle relaxation in allergic asthma. Respir Res 2006; 7: 6.
22. Maarsingh H, Zuidhof AB, Bos IS, et al: Arginase inhibition protects against allergic airway obstruction, hyperreponsiveness and inflammation. Am J Respir Crit Care Med 2008; 178: 565-573.
23. Bratt JM, Franzi LM, Linderholm AL, et al: Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol 2009; 234: 273-280.
24. Ckless K, Lampert A, Reiss J, et al: Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein-S nitrosylation and tyrosine nitration. J Immunol 2008; 181: 4255-4264.
25. Niese KA, Collier AR, Hajek AR, et al: Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol 2009; 10: 33.
26. Hecker M, Nematollahi H, Hey C, et al: Inhibition of arginase by N-G-hydroxy-L-arginine in alveolar macrophages-implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett 1995; 359: 251-254.
27. Maarsingh H, Volders HH, Zaagsma J, et al: L-ornithine causes NO deficiency and airway hyperresponsiveness in perfused guinea pig tracheal preparations in vitro. Naunyn-Schmiedbergs Arch Pharmacol 2007; 375: 151.
28. Asano K, Chee CB, Gaston B, et al: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91: 10089-10093.
29. Hamid Q, Springall DR, Riveros-Moreno V, et al: Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513.
30. Modolell M, Corraliza IM, Link F, et al: Reciprocal regulation of the nitric oxide synthase/ arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 2005; 25: 1101-1104.
31. Zimmermann N, King NE, Laporte J, et al: Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111: 1863-1874.
32. Maarsingh H, Bossenga BE, Bos IST, et al: L-arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur Respir J 2009; 34: 191-199.
33. North ML, Khanna N, Marsden PA, et al: Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296:L911-L920.
34. Abe M, Hayashi Y, Murai A, et al: Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. Free Radic Biol Med 2006; 40: 1083-1095.
35. Yang M, Rangasamy D, Matthaei KI, et al: Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 2006; 177: 5595-5603.
36. Zimmerman N, King NE, Laporte J, et al: Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111: 1863-1874.
37. Sandler NG, Mentink-Kane MM, Cheever AW, et al: Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 reponses in tissue repair. J Immunol 2003; 171: 3655-3667.
38. Lewis CC, Yang JY, Huang X, et al: Diseasespecific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 2007; 177: 376-387.
39. Hyseni X, Soukup JM, Huang YC: Pollutant particles induce arginase II in human bronchial epithelial cells. J Toxicol Environ Health A 2012; 75: 624-636.
40. Breton CV, Byun HM, Wang X, et al: DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med 2011; 184: 191-197.
41. Kochanski L, Kossmann S, Rogala E, et al: Sputum arginase activity in bronchial asthma. Pneumonol Pol 1980; 48: 329-332.
42. North ML, Khanna N, Marsden PA, et al: Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296:L911-L920.
43. Li H, Romieu I, Sienra-Monge J-J, et al: Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol 2006; 117: 119-126.
44. Morris CR, Morris SM Jr, Hagar W, et al: Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003; 168: 63-69.
45. Maarsingh H, Dekkers BG, Zuidhof AB, et al: Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J 2011; 38: 318-328.
46. Messeri-Dreissig MD, Hammermann R, Mossner J, et al: In rat alveolar macrophages lipopolysaccharides exert divergent effects on the transport of the cationic amino acids Larginine and L-ornithine. Naunyn-Schmiedbergs Arch Pharmacol 2000; 361: 621-628.
47. Bogle RG, Baydoun AR, Pearson JD, et al: L-arginine transport is increased in macrophages generating nitric oxide. Biochem J 1992; 284: 15-18.
48. Hammermann R, Hirschmann J, Hey C, et al: Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am J Respir Cell Mol Biol 1999; 21: 155-162.
49. Nicholson B, Manner CK, Kleeman J, et al: Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem 2001; 276: 15881-15885.
50. Manner CK, Nicholson B, MacLeod CL: CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes. J Neurochem 2003; 85: 476-482.
51. Schapira RM, Wiessner JH, Morrisey JF, et al: L-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo. Am J Respir Cell Mol Biol 1998; 19: 308-315.
52. Meurs H, Schuurman FE, Duyvendak M, et al: Deficiency of nitric oxide in polycationinduced airway hyperreactivity. Br J Pharmacol 1999; 126: 559-562.
53. Yahata T, Nishimura Y, Maeda H, et al: Modulation of airway responsiveness by anionic and cationic polyelectrolyte substances. Eur J Pharmacol 2002; 434: 71-79.
54. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, et al: Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 1996; 153: 1697-1701.
55. Sugiura H, Ichinose M, Oyake T, et al: Role of peroxynitrite in airway microvascular hyperpermeability during late allergic phase in guinea pigs. Am J Respir Crit Care Med 1999; 160: 663-671.
56. Saleh D, Ernst P, Lim S, et al: Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12: 929-937.
57. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, et al: Peroxynitrite in airway diseases. Clin Exp Allergy 1998; 28: 1464-1473.
58. Xia Y, Roman LJ, Masters BS, et al: Inducible nitric oxide synthase generates superoxide anion from the reductase domain. J Biol Chem 1998; 273: 22635-22639.
59. Scott JA, North ML, Rafii M, et al: Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med 2011; 184: 779-785.
60. Riccioni G, Bucciarelli V, Verini M, et al: ADMA, SDMA, L-arginine and nitric oxide in allergic pediatric bronchial asthma. J Biol Regul Homeost Agents 2012; 26: 561-566.
61. Sapienza MA, Kharitonov SA, Horvath I, et al: Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 1998; 53: 172-175.
62. deBoer J, Duyvendak M, Schuurman FE, et al: Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea pigs. Br J Pharmacol 1999; 128: 1114-1120.
63. Prado CM, Leick-Maldonado EA, Yano L, et al: Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell Mol Biol 2006; 35: 457-465.
64. Mabalirajan U, Ahmad T, Leishangthem GD, et al: L-arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation. Int Immunopharmacol 2010; 10: 1514-1519.
65. Mabalirajan U, Ahmad T, Leishangthem GD, et al: Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010; 125: 626-635.
66. Grasemann H, Kurtz F, Ratjen F: Inhaled Larginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 208-212.
67. Chambers DC, Ayres JG: Effect of nebulised L-and D-arginine on exhaled nitric oxide in steroid naive asthma. Thorax 2001; 56: 602-606.
68. Takano H, Lim HB, Miyabara Y, et al: Oral administration of L-arginine potentiates allergen-induced airway inflammation and expression of interleukin-5 in mice. J Pharmacol Exp Ther 1998; 286: 767-771.
69. Al Qadi-Nassar B, Bichon-Laurent F, Portet K, et al: Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice. Fundam Clin Pharmacol 2007; 21: 611-620.
70. de Gouw HW, Verbruggen MB, Twiss IM, et al: Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma. Thorax 1999; 54: 1033-1035.
71. Kenyon N, Last M, Bratt J, et al: L-arginine supplementation and metabolism in asthma. Pharmaceuticals 2011; 4: 187-201.
72. Waugh WH, Daeschner III CW, Files BA, et al: Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc 2001; 93: 363-371.
73. Morris C, Kuypers FA, Hagar R, et al: Metabolic fate of oral glutamine supplementation within plasma and erythrocytes of patients with sickle cell disease: preliminary pharmacokinetics results (abstract). Blood 2010; 116: 1636.
74. Wenzel S, Holgate ST: The mouse trap: it still yields few answers in asthma. Am J Respir Crit Care Med 2006; 174: 1173-1178.